Tag: Glucagon

Biodel logo

Biodel to Produce Glucagon Rescue Product

Biodel has announced plans to submit a New Drug Application (NDA) to the FDA in 2015 for a novel glucagon rescue device to treat severe hypoglycemia. Having previously signed a long-term commercial supply agreement for bulk glucagon, Biodel expects to select a final formulation of its novel glucagon therapy...
0 Shares
Biodel logo

Biodel Receives NIH Grant to Develop Glucagon Formulations For Artificial Pancreas

The Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel Inc. a grant for the development of novel and stable glucagon formulations for use in an artificial pancreas, also known as a closed loop pump system. The SBIR program is a highly competitive program that encourages domestic small businesses to engage in Federal Research/Research and Development that has the potential for commercialization.
0 Shares

Lilly Diabetes Launches Glucagon Mobile App

Lilly Diabetes today announced the release of a new mobile application designed for caregivers and healthcare providers who support people with type 1 diabetes. The Lilly Glucagon Mobile App is a tool to teach how to use Glucagon for injection, through simulated practice. Glucagon, 1 mg (1 unit), is indicated to treat severe hypoglycemia (low blood sugar). Severe hypoglycemia due to insulin may result in loss of consciousness (insulin coma).
0 Shares
utsouthwestern - Logo

Destroying Glucagon Receptors May Cure Diabetes

New findings by researchers at UT Southwestern Medical Center may hold a cure for type 1 diabetes. According to the findings, type 1 diabetes could be converted to an asymptomatic, non-insulin-dependent disorder by eliminating the actions of a specific hormone...
0 Shares